» Articles » PMID: 1445234

Secretion of 72 KDa Type IV Collagenase/gelatinase by Cultured Human Lipocytes. Analysis of Gene Expression, Protein Synthesis and Proteinase Activity

Overview
Journal Biochem J
Specialty Biochemistry
Date 1992 Nov 1
PMID 1445234
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The matrix metalloproteinases play an important role in matrix degradation, but there is limited information about this family of enzymes in either normal or diseased human liver. In this study, we have examined the synthesis of a 72 kDa type IV collagenase/gelatinase by human hepatic lipocytes in primary culture. Hepatic lipocytes were isolated from wedges of normal human donor liver by Pronase/collagenase perfusion, purified by density-gradient centrifugation, and established in primary culture on uncoated plastic. By Northern-blot analysis, the total RNA extracted from cultured human lipocytes was found to contain 3.4 kb mRNA for the 72 kDa type IV collagenase/gelatinase. Low levels of expression of this mRNA were observed in freshly isolated lipocytes but expression increased with the duration of lipocyte culture. Using anti-human 72 kDa type IV collagenase/gelatinase IgG, synthesized enzyme was immunolocalized to monensin-treated human lipocyte cultures. De novo synthesis and secretion of 72 kDa type IV collagenase/gelatinase were confirmed by immunoprecipitation of radiolabelled enzyme from medium obtained from [35S]methionine-treated cells. Activity of the secreted enzyme was demonstrated by gelatin-zymography and by degradation of soluble, radiolabelled [14C]gelatin. The enzyme was released both in active and latent pro-enzyme forms and its inhibition profile was that of a metalloproteinase. These studies indicate that cultured human hepatic lipocytes express the gene for the 72 kDa type IV collagenase/gelatinase, and secrete this enzyme, particularly in prolonged primary culture. As this enzyme exhibits degradative activity against basement membrane collagen, its release by activated hepatic lipocytes in the space of Disse could lead to disruption of the normal subendothelial liver matrix. It is suggested that this enzyme may have an important role in human liver injury and fibrosis.

Citing Articles

Overexpression of Tumor Necrosis Factor-Like Ligand 1 A in Myeloid Cells Aggravates Liver Fibrosis in Mice.

Guo J, Luo Y, Yin F, Huo X, Niu G, Song M J Immunol Res. 2019; 2019:7657294.

PMID: 30906791 PMC: 6393882. DOI: 10.1155/2019/7657294.


Role of canonical Hedgehog signaling pathway in liver.

Gao L, Zhang Z, Zhang P, Yu M, Yang T Int J Biol Sci. 2018; 14(12):1636-1644.

PMID: 30416378 PMC: 6216024. DOI: 10.7150/ijbs.28089.


Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide.

Wu H, Chuang Y, Huang C, Chang M Exp Anim. 2017; 67(1):41-49.

PMID: 28845018 PMC: 5814313. DOI: 10.1538/expanim.17-0053.


Mice deficient in N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase exhibit enhanced liver fibrosis and delayed recovery from fibrosis in carbon tetrachloride-treated mice.

Habuchi H, Ushida T, Habuchi O Heliyon. 2016; 2(8):e00138.

PMID: 27547834 PMC: 4983273. DOI: 10.1016/j.heliyon.2016.e00138.


Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.

Coombes J, Swiderska-Syn M, Dolle L, Reid D, Eksteen B, Claridge L Gut. 2014; 64(7):1120-31.

PMID: 24902765 PMC: 4487727. DOI: 10.1136/gutjnl-2013-306484.


References
1.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

2.
Arthur M . Matrix degradation in the liver. Semin Liver Dis. 1990; 10(1):47-55. DOI: 10.1055/s-2008-1040456. View

3.
Davis B, Pratt B, Madri J . Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J Biol Chem. 1987; 262(21):10280-6. View

4.
Yokoi Y, NAMIHISA T, Matsuzaki K, Miyazaki A, Yamaguchi Y . Distribution of Ito cells in experimental hepatic fibrosis. Liver. 1988; 8(1):48-52. DOI: 10.1111/j.1600-0676.1988.tb00966.x. View

5.
Mak K, Lieber C . Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology. 1988; 8(5):1027-33. DOI: 10.1002/hep.1840080508. View